phenotypes of glioma cells. In an effort to define the
contribution of each of these kinases, Dr. Joseph Loftus
Validated siRNAs targeting PTK2 and
PTK2B to knock down the expression of each of these kinases.
As seen in Figure 2, the expression of PTK2B was
significantly reduced following transfection of cells with the PTK2B validated
siRNA, but PTK2B expression was unchanged relative to the control in cells
transfected with the PTK2 validated siRNA. Similarly, PTK2 expression
was significantly reduced following transfection of cells with the PTK2
validated siRNA but unchanged following transfection with the PTK2B validated
siRNA. Successful suppression of PTK2 and PTK2B gene expression will allow
future analysis of the role of these kinases in integrin signaling and
other cellular phenotypes.
Figure 2. Specific
Gene Silencing of the Related Focal Adhesion Kinases FAK and Pyk2 .
HeLa cells were transfected with PTK2,
PTK2B, or a control (GAPDH) validated siRNA at a final concentration of
25 nM. 48 hours after transfection, cells were harvested and protein expression
levels were analyzed by Western blot with antibodies specific for Focal
Adhesion Kinase, FAK (PTK2), or Proline-rich tyrosine
kinase 2, Pyk2 (PTK2B).
back to top
Page: All 1 2 3 4 5
Related biology technology :
1. YOUR DATA:
Direct Real-time RT-PCR on Sympathetic Neuron Lysates
Silencing of Focal Adhesion Kinases with Silencer Validated siRNAs
2. Measuring RNase Activity A Real-time Kinetic Analysis
3. Ready for Real-time in 5 Minutes
4. New Kit Generates Exceptionally Pure Total RNA for RT-PCR
5. Brilliant Core Reagent Kits for QPCR and QRT-PCR
6. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
7. prostar RT-PCR Systems for Robust High-Fidelity RNA Amplification
8. Performance Comparisons of Commercial RT-PCR Systems
9. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
10. RT-PCR Primers for the Study of Apoptosis
11. cMaster RTplusPCR System for increased sensitivity and product length
(Date:3/3/2015)... Genedata, a leading provider of advanced ... research, today announced that Pfizer Inc. has licensed ... at Pfizer biopharma research and development sites in ... global deployment and roll out project at Pfizer’s ... (CTI), and Pharmaceutical Sciences groups. , “Pfizer ...
(Date:3/3/2015)... 2015 Research and Markets ( ... PharmaBiotech,s new report "Personalized Medicine - Scientific ... , The aim of personalized medicine ... drug to the right patient and, in some ... a patient according to his/her genotype. This report ...
(Date:3/3/2015)... , Mar. 03, 2015 Research and ... the addition of Jain PharmaBiotech,s new report ... to their offering. , Gene ... vectors, nonviral vectors and cell therapy with genetically ... of drug delivery and various routes of administration ...
(Date:3/3/2015)... 2015 Elsevier,s DirectCourse online ... competency-based training to comply with new CMS requirements ... a new crosswalk tool to help providers ... for direct service workers as a means to comply ... regulations. CMS amended the regulations, effective March ... Breaking Biology Technology:Genedata Biologics Licensed by Pfizer Inc. 2Genedata Biologics Licensed by Pfizer Inc. 3Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 2Global Personalized Medicine Market Report 2015 - Scientific and Commercial Aspects 2014-2024 3Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 2Gene Therapy Market Report 2014-2024 - Technologies, Markets and Companies 3Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 2Elsevier's DirectCourse Can Help States Meet and Exceed New CMS Requirements for Home and Community-Based Services 3
... to fuel requires several steps: chemical pretreatment to break ... to remove the toxic chemicals required in pretreatment, and ... Virginia Tech researchers have discovered an enzyme mixture that ... biomass (hydrolysate), meaning that the detoxification step is unnecessary, ...
... 2011 Cadence Pharmaceuticals, Inc. (Nasdaq: ... commercializing proprietary product candidates principally for use in the hospital ... and full year ended December 31, 2010 financial results on ... host a conference call and live webcast to discuss the ...
... Bulletin Board: GOVX ), an Atlanta-based biotechnology company ... its financial results for the fourth quarter and year ended ... of $478,784 for the fourth quarter ended December 31, 2010, ... comparable period in 2009. For the full year of 2010, ...Cached Biology Technology:Enzyme cocktail could eliminate a step in biofuel process 2GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results 2GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results 3GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results 4GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results 5GeoVax Labs Reports Fourth Quarter and Year-End 2010 Financial Results 6
(Date:2/5/2015)... 5, 2015 Marken is starting its 35 th ... launched a new marketing campaign to solidify its place ... new campaign focuses on First as a ... The first headline in the series, ... with its client,s priorities. Marken recognizes the need to ...
(Date:2/5/2015)... 27, 2015 Marvin Test Solutions ... innovative test solutions for military, aerospace, and ... its TS-323 GENASYS Test Platform ... GENASYS is a high-performance PXI-based system designed ... that require performance functional testing. GENASYS features ...
(Date:2/5/2015)... DUBLIN , Jan. 28, 2015 Research ... announced the addition of the "Global Biometrics ... Use, Regions and Countries " report to their ... market, Asia-Pacific is anticipated ... by 2015, owing to increasing government spending towards ... Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
Rat Antibody to Mouse TCR VB8.1,8.2:FITC Recognises the V beta 8.1 and V beta 8.2 determinants of the murine T cell receptor. Specificity: mouse TCR VB8.1 and 8.2...
Vesicle Associated Membrane Protein (VAMP 1/2)...
Anti-Mouse Valpha 2 TCR, Purified (Clone B20.1) (rat IgG2a)...Biology Products:
Rat Anti-Mouse TCR VB8.1,8.2 Monoclonal Antibody, FITC Conjugated, Clone KJ16 from GeneTexSheep Anti-fli-1 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.Sheep Anti-Human Vesicle Associated Membrane Protein (VAMP 1/2) Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.Rat Anti-Mouse TCR, Va 2 Monoclonal Antibody, Unconjugated, Clone B20.1 from CEDARLANE Laboratories Limited